Evan Anderson, CEO & Board Member, Luma Therapeutics
Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
From the Luma Therapeutics website:
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
Frank Dobbin: Reimagining Diversity
Peter Hames: The Only Person Awake
Chris Hemphill: The Ethics of Our Algorithms
Lindy Greer: The Culture of Curiosity
Mehdi Peikar: Fighting Tooth and Nail
Michael Favet: Following Your Passion
Nicole Malachowski: Breaking Through the Noise
Stephanie Tilenius: Treating the Body and the Mind
Joel Klein: Making the Most of IT
Chris McFadden: The Future of Care
Vinod Khosla: Hubris and Paranoia
Hemant Taneja: Greater Intention
Kevin Coloton: The Maturity Curve
David Kuraguntla: The Internet of the Body
Paddy Padmanabhan: Accelerating the Future
Carine Carmy: From the Inside Out
Ivana Schnur: The Healing Contract
Chyrell D. Bellamy: The Value of Lived Experience
Erin Parks: Treating Eating Disorders
Eric Dy: To Providers or Consumers?
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money